Koi Biotherapeutics Inc.
Biotechnology company · Newark, Delaware, United States
Koi Biotherapeutics Inc. is a biotechnology company headquartered in Newark, Delaware, United States. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $1.3 million in total, most recently in 2025.
Profile compiled from public records. Is this your company? Request a correction or update
Koi Biotherapeutics at a glance
Typebiotechnology company
HeadquartersNewark, Delaware, United States
Employees (self-reported, 2025)2
What does Koi Biotherapeutics do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $1.3 million in total (2025). NIH funding came from the National Cancer Institute.
Frequently asked questions about Koi Biotherapeutics
Where is Koi Biotherapeutics headquartered?
Koi Biotherapeutics Inc. is headquartered in Newark, Delaware, United States.
What does Koi Biotherapeutics do?
Koi Biotherapeutics Inc. is a biotechnology company.
Similar companies
- Toivoa, IncNewark, Delaware, United States
- Cell Podium LLCNewark, New Jersey, United States
- Virion Therapeutics, LLCNewark, Delaware, United States
- Simphotek, Inc.Newark, New Jersey, United States
- Fauna Bio IncorporatedNewark, California, United States
- Kaneka Americas Holding IncNewark, California, United States
- Nangiotx IncNewark, New Jersey, United States
- Filamentech, Inc.Newark, Delaware, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences